To meet a broad range of skin health needs, we offer a range of leading medical and consumer skin health brands, through three business units: Prescription, Aesthetics, and Consumer care.
Key facts
7 innovation areas
We focus our innovation on 7 areas: acne, rosacea, psoriasis, atopic dermatitis, skin aging, sun protection and skin cancer.
5 manufacturing sites
In 2018, the 1,200+ employees at our 5 manufacturing sites produced 215 million units. We make 75% of our products in house.
World presence
We operate from 50 sites in 40 countries, with our headquarters in Lausanne, Switzerland.
Sales by region
North America 50.4%
International 49.6%
Sales by business
Consumer 41%
Aesthetics 35%
Prescription 24%
Creating shared value
We collaborate with the broad skin health community:
Leadership
Find out about our leadership team by clicking here.
A timeline of our history
1981
Foundation of Galderma
1984
Galderma discovers Adapalene
1986
First commercial operations
1995
Acne treatment Differin launch
2000
Opening of production site in Baie d’Urfé, Canada
2001
Licensing agreement for Metvix (Skin cancer)
2004
Opening of production site in Hortolândia, Brazil
2007
Launch of Differin 0.3%
2008
Launch of Epiduo
2009
Launch of Azzalure and Restylane Injector